Retatrutide — lab test, May 2026
COA YLT-SFS matches Uzorak's public record. So this test doesn't rest on our review alone — the lab confirms it too.
YLT-SFSTest results
Not on file for this certificate: endotoxins, sterility and heavy metals. A purity figure says nothing about those.
About this test
Label 20 mg · Lab measured 15.84 mg
79% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 4 mg using the measured mass, against 5 mg on the label — 21% less.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | YLT-SFS |
|---|---|
| Portal lookup | ✓ Lab-verified |
| PDF vs portal | Uzorak's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Retatrutide, performed by Uzorak on May 22, 2026. Reported purity: 99.59%. Net content: 15.84 mg against 20 mg labeled (79% of label). Tested content is 21% below the labeled amount. Batch DB-R20-001. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion